Literature DB >> 3574581

Cavernous sinus meningiomas.

F A Cioffi, F P Bernini, A Punzo, M Natale, I Muras.   

Abstract

Analysing 12 cases of cavernous sinus meningiomas the authors conclude that: the clinical history is characteristic; CT scan has proved to be more sensitive than carotid angiography in detecting small lesions. However in large lesions the vascular supply pattern is the only feature that exactly identifies the site of the lesion. Both angiography and CT scan allow a near definitive diagnosis of meningioma; because of their location it is almost always impossible to remove these tumours completely. Actually the best treatment is a piecemeal subtotal microsurgical removal via a subtemporal approach. Radiotherapy is indicated for partially resected lesions. On the basis of the revision of the anatomy of this region and looking forward to a widespread use of the Cavitron in neurosurgery, a more radical approach to this lesion is foreseen.

Entities:  

Mesh:

Year:  1987        PMID: 3574581     DOI: 10.1055/s-2008-1053654

Source DB:  PubMed          Journal:  Neurochirurgia (Stuttg)        ISSN: 0028-3819


  4 in total

1.  Cavernous sinus meningioma presenting as orbital apex syndrome. Diagnostic methods of dynamic MRI, spoiled GRASS (SPGR) image.

Authors:  F Ikawa; T Uozumi; K Kiya; K Arita; K Kurisu; K Harada
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

2.  Invasion of the cavernous sinus by medial sphenoid meningioma--"radical" surgery and recurrence.

Authors:  G Kleinpeter; F Böck
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

3.  Ophthalmoplegia as an unusual initial symptom of non-Hodgkins' lymphoma in the head and neck.

Authors:  A F Temmel; C Czerny; M Susani; M Kautzky
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 4.  Midline Skull Base Meningiomas: Transcranial and Endonasal Perspectives.

Authors:  Ciro Mastantuoni; Luigi Maria Cavallo; Felice Esposito; Elena d'Avella; Oreste de Divitiis; Teresa Somma; Andrea Bocchino; Gianluca Lorenzo Fabozzi; Paolo Cappabianca; Domenico Solari
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.